CompletedNot Applicable

Prognostic Evaluation Prediction Model Survival Spinal Epidural Metastases

Netherlands428 participantsStarted 2021-01-01

Plain-language summary

Patients with symptomatic spinal metatstasis will be prosepectively included in a database after theu signes informed consent. Minimally six months after inclusion the survival status is analyzed. These are correlated with factors that are used in an earlier develloped prediction model

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * patients with spinal spinal metastasis * symptomatic * adult * informed consent Exclusion Criteria: * not understanding informed consent

What they're measuring

survival after diagnosis of spinal metastasis

Timeframe: minimal 6 months after inclusion

Trial details

NCT IDNCT06411015

SponsorRadboud University Medical Center

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-01-01

View on ClinicalTrials.gov More Predictive Cancer Model trials